21.11.2014 Views

o_1977r8vv9vk1ts2ms0kd8pksa.pdf

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

96 D. Maulik<br />

Acoustic Output of Diagnostic<br />

Ultrasound Devices<br />

and Its Regulation<br />

A central issue in the safe use of diagnostic ultrasound<br />

is the power output of the instruments. By enacting<br />

the Medical Devices Amendment to the US<br />

Food, Drug and Cosmetic Act on May 28, 1976, the<br />

United States Congress empowered the FDA to control<br />

the output limits to the devices through the mandatory<br />

premarketing approval process. The approval<br />

was based on the manufacturers' ability to demonstrate<br />

substantial equivalence of each new device in<br />

safety and efficacy to diagnostic ultrasound devices<br />

on the market prior to the enactment date. The principle<br />

of substantial equivalence in safety was based<br />

on the assumption that the pre-enactment devices<br />

were safe and was supported by the available scientific<br />

data which provided no evidence of independently<br />

confirmed adverse significant biological effects in<br />

mammalian tissue exposed in vivo to I SPTA below 100<br />

mW/cm 2 [11]. In 1985, the FDA introduced the application<br />

specific output standards of substantial equivalence<br />

covering four areas of use: cardiac, peripheral<br />

vascular, fetal imaging and other, and ophthalmic. In<br />

the early 1990s, based on an NCRP technical report<br />

called the Output Display Standard (ODS) [12], the<br />

AIUM and the National Electrical Manufacturers Association<br />

(NEMA) led an initiative to increase the intensity<br />

in exchange for on-screen labeling which resulted<br />

in a modification of the existing regulation by<br />

the FDA. The track 3 option allows devices to increase<br />

the overall maximum output limit to 720 mW/<br />

cm 2 provided they incorporate the ODS [13]. Equipments<br />

used in ophthalmology were exempted. The<br />

track 3 devices can have a substantial increase in the<br />

power output and it is the responsibility of the sonographer<br />

to use the display to limit the intensity of fetal<br />

exposure. Given the potential for adverse effects,<br />

the need for user education and training in this area<br />

can not be overstressed. This provides a compelling<br />

rationale for this chapter.<br />

The ODS consists of two risk indicators, a thermal<br />

index (TI) for thermal bioeffects, and a mechanical<br />

index (MI) for nonthermal bioeffects [12]. The TI<br />

was further refined in 1998 adding three tissue-specific<br />

TI models [14]. These are further described below:<br />

n The TI is the ratio of total acoustic power to the<br />

acoustic power that would be required to raise<br />

temperature by 18C for a specific tissue model. As<br />

a ratio it is dimensionless and provides an estimate<br />

of maximum temperature rise rather than the<br />

actual increase. Thus a TI of 2 indicates a higher<br />

temperature elevation than a TI of 1, but does not<br />

imply an actual rise of 2 8C in the insonated tissue.<br />

There are three tissue-specific thermal indices:<br />

± TIS=Thermal index for soft tissue is concerned<br />

with temperature rise within homogeneous soft<br />

tissue.<br />

± TIB=Thermal index bone is related to temperature<br />

elevation in bone at or near the focus of<br />

the beam.<br />

± TIC=Thermal index cranial bone indicates temperature<br />

increase of bone at or near the surface,<br />

such as during a cranial examination.<br />

n The MI is also a dimensionless quantity and is derived<br />

from the peak rarefactional pressure at the<br />

point of the maximal intensity divided by the<br />

square root of the center frequency of the pulse<br />

bandwidth. It is an indicator of potential nonthermal<br />

bioeffects, especially those that are cavitationrelated.<br />

According to the FDA, the MI may range<br />

up to 1.9 except for ophthalmic usage. The higher<br />

the value of MI, the higher the risk of a mechanical<br />

effect.<br />

The relevance and practical utilization of the indices<br />

for safe use of diagnostic sonography are further discussed<br />

later.<br />

Mechanisms of Bioeffects<br />

Any review of bioeffects of ultrasound must include<br />

considerations of the known mechanisms by which<br />

propagating ultrasound reacts with biological systems.<br />

The following effects are currently recognized:<br />

1. Thermal effects which are mediated by insonationinduced<br />

tissue heating<br />

2. Nonthermal or mechanical effects which include<br />

those not related to heat generation.<br />

The thermal and the mechanical effects of diagnostic<br />

acoustic exposure and their relevance for the safety<br />

of Doppler ultrasound usage are further discussed below.<br />

Thermal Effects<br />

As a beam of ultrasound propagates through a tissue<br />

medium, a portion of its energy is absorbed and converted<br />

to heat because the frictional forces in the medium<br />

oppose the ultrasound-related molecular oscillations.<br />

The rate of temperature elevation in the insonated<br />

tissue is determined by the balance between<br />

the rates of heat production and of heat dissipation.<br />

The rate of heat generation depends on the characteristics<br />

of the transmitted ultrasound and the tissue<br />

medium [15].

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!